查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1458413

動物傳染病診斷市場評估：依技術、動物類型、感染類型、最終用戶和地區劃分的機會和預測（2017-2031）

Veterinary Infectious Disease Diagnostics Market Assessment, By Technology, By Animal Type, By Infection Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 231 Pages | 商品交期: 3-5個工作天內

價格

全球獸醫傳染病診斷市場規模將從2023年的21.1億美元成長到2031年的42.8億美元，預計在2024-2031年期間將以9.25%的複合年增長率成長。

伴侶動物飼養的增加、研發活動的增加、肉製品消費的增加以及人畜共患疾病盛行率的增加推動了市場擴張。

伴侶動物越來越受歡迎：

人們越來越多地使用伴侶動物是因為它們表現出許多情感上的好處，包括無條件的愛和忠誠。這些動物還提供多種健康益處，包括讓它們的照護者過著更積極、更健康的生活方式。伴侶動物已被證明可以減少困擾精神疾病患者的各種負面情緒，包括憂鬱、壓力、孤立、焦慮和恐懼。它還為您的大腦和身體提供強大的化學物質，促進積極情緒。人們越來越多地飼養伴侶動物，以便讓患有精神疾病的人在日常生活中獲得正常和穩定的感覺。

增加研發活動：

對開發新穎和先進診斷解決方案的投資以及中小企業和新創企業的不斷湧現正在為市場創造利潤豐厚的成長機會。世界各地獸醫醫療基礎設施的迅速擴張也促進了此類活動。在診斷過程中，研發活動透過將概念和想法轉化為診斷技術和工具，幫助研究人員應對各種課題。

北美預計將佔據主要市場佔有率：

先進診斷解決方案的增加、高可支配收入、寵物保險的日益普及以及寵物和伴侶動物擁有量的增加是支持北美獸醫傳染病診斷市場成長的一些關鍵因素。根據《Forbes》報道，過去幾年美國的寵物擁有率大幅上升。截至 2024 年，估計該國約 66% 的家庭擁有寵物。由於各種主要參與者的強大存在以及寵物醫療基礎設施的擴張，新穎產品和服務的可用性不斷增加，進一步推動了北美的市場需求。

本報告調查了全球動物傳染病診斷市場，並提供了市場定義和概述、市場規模趨勢和預測、各個細分市場和地區的詳細分析、行業結構、影響市場成長的因素分析、我們編製了案例研究、競爭格局、簡介主要公司等。

目錄

第一章研究方法論

第二章 專案範圍與定義

第三章執行摘要

第四章 全球動物傳染病診斷市場展望

  • 市場規模/預測
  • 依技術
    • 分子診斷
    • 免疫診斷
    • 尿液分析
    • 血液學
    • 其他
  • 依動物類型
    • 食用動物
    • 寵物
  • 依感染類型
    • 病毒感染
    • 寄生蟲感染
    • 細菌感染
    • 其他
  • 依最終用戶
    • 獸醫實驗室/診所
    • 護理點/院內檢測
    • 參考實驗室
    • 其他
  • 依地區
    • 北美
    • 南美洲
    • 歐洲
    • 亞太地區
    • 中東/非洲
  • 依公司劃分的市場佔有率

第五章全球動物傳染病診斷市場展望：依地區

  • 北美
  • 南美洲
  • 歐洲
  • 亞太地區
  • 中東/非洲

第 6 章 市場測繪

  • 依機型
  • 依類型
  • 依最終用戶
  • 透過子框架
  • 依地區

第七章 宏觀環境與產業結構

  • 供需分析
  • 進出口分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第八章市場動態

  • 增長動力
  • 成長限制因素（課題與限制）

第九章 監理架構與創新

  • 專利情況
  • 監管審批
  • 創新/新興技術

第十章 主要公司情況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 名市場領導者的市場收入分析
  • 併購/合資（如適用）
  • SWOT分析（5家參與企業）
  • 專利分析（如果適用）

第11章價格分析

第十二章案例研究

第十三章 主要公司展望

  • Biomerieux S.A.
  • Zoetis, Inc.
  • IDEXX Laboratories, Inc.
  • Indical Bioscience
  • Heska Corporation
  • IDVet
  • Thermo Fisher Scientific Inc.
  • Virbac
  • Randox Laboratories Ltd.
  • Neogen Corporation

第十四章 戰略建議

第十五章關於我們公司/免責聲明

Product Code: MX11210

Global veterinary infectious disease diagnostics market is projected to witness a CAGR of 9.25% during the forecast period 2024-2031, growing from USD 2.11 billion in 2023 to USD 4.28 billion in 2031. The market expansion is supported by increasing adoption of companion animals, rising research and development activities, growing consumption of meat products, and increasing prevalence of zoonotic diseases.

The increasing adoption of pets due to rising nuclear households and urbanization is propelling the requirement for veterinary infectious disease diagnostic devices and solutions. Pet owners are extremely invested in the health and well-being of their pets and ensure that they are provided with essential veterinary care. The rise in demand for veterinary infectious disease diagnostic solutions can also be attributed to the growing prevalence of various vector-borne and zoonotic diseases due to climate change, the introduction of exotic vectors, and habitat modification. To combat the spread of such diseases, the requirement for precise and rapid diagnostic tools is increasing, boosting the market expansion.

The market is also expected to witness significant growth over the forecast period owing to enhanced capabilities of diagnostic devices and the increasing availability of technologically advanced diagnostic methods, including RTPCR. Furthermore, the growing popularity of pet insurance and increasing concerns about the wellbeing of pets, coupled with rising disposable incomes, is bolstering the market growth. Growing awareness about regular health checkups for animals is also boosting the market demand. According to Forbes, approximately 5.36 million pets are insured in America, of which 20% are cats and 80% are dogs.

Growing Popularity of Companion Animals

The increased adoption of companion animals can be attributed to the various emotional benefits offered by them, including unconditional love and loyalty. These animals also offer various health benefits, including empowering their caretakers to lead more active and healthier lifestyles. Companion animals have been proven to reduce different overwhelming negative emotions that trouble those with mental illnesses, such as depression, stress, isolation, anxiety, and fear. They also provide the brain and body with powerful chemicals for boosting positive emotions. The adoption of companion animals is also increasing as they provide a sense of consistency and normalcy, stabilizing routines to individuals living with mental illness.

According to the Progressive Animal Welfare Services (PAWS), approximately one in five Canadians live with some form of mental illness as per the Mental Health Commission of Canada. It is estimated that 8.9 million Canadians (almost 23% of the country's population) will be suffering from some sort of mental illness by 2041.

Increasing Research and Development Activities

Growing investments towards the development of novel and advanced diagnostic solutions and the increasing emergence of smaller companies and startups are providing lucrative growth opportunities to the market. Such activities are also promoted by the rapid expansion of the animal healthcare infrastructure in various regions across the globe. In the diagnostic journey, research and development activities aid researchers in addressing the different challenges by translating concepts and ideas into diagnostic technologies and tools, which can then be used for identifying different infectious diseases in animals. Over the past few years, small companies and startups, including Wellness Ready, have increased their efforts toward introducing products essential for conducting point-of-care tests in veterinary medicine. Due to the different advantages associated with point-of-care tests, such as minimal sample processing, elimination of sample transportation, minimal sample requirement, and simple analytic process, their demand has been increasing for diagnosing veterinary infectious diseases.

North America Expected to Account for Significant Market Share

The increasing availability of advanced diagnostic solutions, high disposable incomes, the growing popularity of pet insurance, and rising adoption of pets and companion animals are some of the major factors supporting the North America veterinary infectious disease diagnostics market growth. According to Forbes, pet ownership in the United States significantly increased over the past few years. It is estimated that, as of 2024, approximately 66% of the households in the country own a pet. The increasing availability of novel products and services, owing to the strong presence of various key market players and the growing expansion of pet healthcare infrastructure, is further boosting the market demand in North America. Due to the growing consumption of dairy products and meat in the region and increasing awareness about the importance of maintaining the health of food-producing animals, emphasis is being put on ensuring animal health. As per the estimates of the U.S. Department of Agriculture, in 2021, 56.2 pounds of beef per person were available in the United States for human consumption and 68.1 pounds of chicken per person were available.

Immunodiagnostics to Witness Significant Expansion

The expansion of the segment can be attributed to the increased development of advanced diagnostic solutions, platforms, and novel immunoassay formats. The rising utilization of immunoassays for testing infectious diseases, the growing popularity of automation, and increasing concerns about animal fitness and health are further boosting the growth of the segment. The efforts towards enhancing the accuracy of immunoassay-based diagnostic solutions and replacement of traditional methods with tests that require less effort and time and offer improved accuracy are increasing. Strategic collaborations between leading market players are yet another major factor supporting the growth of the segment. For instance, in 2021, Indical, one of the leading providers of innovative veterinary diagnostic solutions, acquired the Svanova product portfolio from Boehringer Ingelheim, becoming the exclusive provider of their veterinary testing products, including approximately twenty-five livestock ELISA assays.

Reference Laboratories Expected to Account for a Significant Market Share

The increase in demand for veterinary infectious disease diagnostic solutions by reference laboratories can be attributed to the rise in number of veterinary practitioners in various regions across the globe and increasing rate of adoption of pets. As per the collected records from the Humane Society and ASPCA, about 3.5 to 4.1 million dogs and cats are adopted every year in the United States. Additionally, the rising investments in laboratory services owing to the growing threat of infectious diseases in animals is further supporting the segment expansion. The growing requirement for high-volume specialty and routine veterinary testing is further expected to boost the demand for reference laboratories.

Future Market Scenario (2024 - 2031F)

Due to the lack of understanding of the mechanism of various infectious diseases in animals and the availability of durable and accurate diagnostic solutions, an increase in research efforts is essential for the provision of accurate diagnostic strategies for eradicating and controlling animal diseases. An increase in investment by pharmaceutical and diagnostic companies, veterinary practices, feline-oriented nonprofits, and academic institutions is also required for creating sustainable and effective antimicrobial stewardship solutions.

In 2023, Virginia Tech Animal Laboratory Services (ViTALS) was selected as part of the Partnership to Improve Early Detection of Emerging Diseases. ViTALS, along with four other laboratories, was selected for a new partnership between the National Bio and Agro-Defense Facility (NBAF) and the National Animal Health Laboratory Network (NAHLN). The partnership is expected to address the looming threat of infectious diseases and will emphasize next-generation sequencing for evaluating and developing diagnostic solutions for zoonotic and animal diseases.

Key Players Landscape and Outlook

Key participants in the veterinary infectious disease diagnostics market are Biomerieux S.A., Zoetis, Inc., IDEXX Laboratories, Inc., Indical Bioscience, and Heska Corporation. The market is expected to witness significant growth in the coming years owing to rising research and development activities and strategic collaborations between key market players.

For instance, in 2022, INDICAL BIOSCIENCE, one of the leading providers of veterinary diagnostic solutions, entered a partnership with Evonik, one of the leading specialty chemicals companies, to expand and develop precision monitoring solutions through the ScreenFloX(R) service in poultry. The ScreenFloX(R) service combines Evonik's Precision Livestock Farming portfolio with INDICAL's veterinary diagnostic capabilities to ensure the provision of proactive analysis of the flock's pathogen status.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Veterinary Infectious Disease Diagnostics Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
    • 4.1.2.By Volume
  • 4.2.By Technology
    • 4.2.1.Molecular Diagnostics
    • 4.2.2.Immunodiagnostics
    • 4.2.3.Urinalysis
    • 4.2.4.Hematology
    • 4.2.5.Others
  • 4.3.By Animal Type
    • 4.3.1.Food Producing Animals
    • 4.3.2.Companion Animals
  • 4.4.By Infection Type
    • 4.4.1.Viral Infections
    • 4.4.2.Parasitic Infections
    • 4.4.3.Bacterial Infections
    • 4.4.4.Others
  • 4.5.By End-user
    • 4.5.1.Veterinary Laboratories and Clinics
    • 4.5.2.Point of Care/In House Testing
    • 4.5.3.Reference Laboratories
    • 4.5.4.Others
  • 4.6.By Region
    • 4.6.1.North America
    • 4.6.2.South America
    • 4.6.3.Europe
    • 4.6.4.Asia-Pacific
    • 4.6.5.Middle East & Africa
  • 4.7.By Company Market Share (%), 2023

5.Global Veterinary Infectious Disease Diagnostics Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Technology
      • 5.1.2.1.Molecular Diagnostics
      • 5.1.2.2.Immunodiagnostics
      • 5.1.2.3.Urinalysis
      • 5.1.2.4.Hematology
      • 5.1.2.5.Others
    • 5.1.3.By Animal Type
      • 5.1.3.1.Food Producing Animals
      • 5.1.3.2.Companion Animals
    • 5.1.4.By Infection Type
      • 5.1.4.1.Viral Infections
      • 5.1.4.2.Parasitic Infections
      • 5.1.4.3.Bacterial Infections
      • 5.1.4.4.Others
    • 5.1.5.By End-user
      • 5.1.5.1.Veterinary Laboratories and Clinics
      • 5.1.5.2.Point of Care/In House Testing
      • 5.1.5.3.Reference Laboratories
      • 5.1.5.4.Others
    • 5.1.6.United States*
      • 5.1.6.1.Market Size & Forecast
      • 5.1.6.1.1.By Value
      • 5.1.6.1.2.By Volume
      • 5.1.6.2.By Technology
      • 5.1.6.2.1.Molecular Diagnostics
      • 5.1.6.2.2.Immunodiagnostics
      • 5.1.6.2.3.Urinalysis
      • 5.1.6.2.4.Hematology
      • 5.1.6.2.5.Others
      • 5.1.6.3.By Animal Type
      • 5.1.6.3.1.Food Producing Animals
      • 5.1.6.3.2.Companion Animals
      • 5.1.6.4.By Infection Type
      • 5.1.6.4.1.Viral Infections
      • 5.1.6.4.2.Parasitic Infections
      • 5.1.6.4.3.Bacterial Infections
      • 5.1.6.4.4.Others
      • 5.1.6.5.By End-user
      • 5.1.6.5.1.Veterinary Laboratories and Clinics
      • 5.1.6.5.2.Point of Care/In House Testing
      • 5.1.6.5.3.Reference Laboratories
      • 5.1.6.5.4.Others
    • 5.1.7.Canada
    • 5.1.8.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East & Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Technology
  • 6.2.By Animal Type
  • 6.3.By Infection Type
  • 6.4.By End-user
  • 6.5.By Region

7.Macro Environment and Industry Structure

  • 7.1.Supply Demand Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat from New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Patent Landscape
  • 9.2.Regulatory Approvals
  • 9.3.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Biomerieux S.A.
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products & Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus & Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Zoetis, Inc.
  • 13.3.IDEXX Laboratories, Inc.
  • 13.4.Indical Bioscience
  • 13.5.Heska Corporation
  • 13.6.IDVet
  • 13.7.Thermo Fisher Scientific Inc.
  • 13.8.Virbac
  • 13.9.Randox Laboratories Ltd.
  • 13.10.Neogen Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14.Strategic Recommendations

15.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 3.Global Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 4.Global Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 5.Global Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 6.Global Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 7.Global Veterinary Infectious Disease Diagnostics Market Share (%), By Region, 2017-2031F
  • Figure 8.North America Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 9.North America Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 10.North America Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 11.North America Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 12.North America Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 13.North America Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 14.North America Veterinary Infectious Disease Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 15.United States Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 16.United States Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 17.United States Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 18.United States Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 19.United States Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 20.United States Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 21.Canada Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 22.Canada Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 23.Canada Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 24.Canada Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 25.Canada Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 26.Canada Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 27.Mexico Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 28.Mexico Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 29.Mexico Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 30.Mexico Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 31.Mexico Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 32.Mexico Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 34.Europe Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 35.Europe Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 36.Europe Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 37.Europe Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 38.Europe Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 39.Europe Veterinary Infectious Disease Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 40.Germany Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 41.Germany Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 42.Germany Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 43.Germany Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 44.Germany Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 45.Germany Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 46.France Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 47.France Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 48.France Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 49.France Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 50.France Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 51.France Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 52.Italy Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 53.Italy Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 54.Italy Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 55.Italy Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 56.Italy Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 57.Italy Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 58.United Kingdom Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 59.United Kingdom Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 60.United Kingdom Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 61.United Kingdom Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 62.United Kingdom Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 63.United Kingdom Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 64.Russia Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.Russia Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 66.Russia Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 67.Russia Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 68.Russia Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 69.Russia Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 70.Netherlands Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 71.Netherlands Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 72.Netherlands Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 73.Netherlands Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 74.Netherlands Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 75.Netherlands Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 76.Spain Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 77.Spain Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 78.Spain Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 79.Spain Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 80.Spain Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 81.Spain Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 82.Turkey Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 83.Turkey Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 84.Turkey Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 85.Turkey Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 86.Turkey Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 87.Turkey Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 88.Poland Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 89.Poland Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 90.Poland Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 91.Poland Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 92.Poland Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 93.Poland Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 94.South America Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 95.South America Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 96.South America Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 97.South America Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 98.South America Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 99.South America Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 100.South America Veterinary Infectious Disease Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 101.Brazil Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 102.Brazil Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 103.Brazil Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 104.Brazil Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 105.Brazil Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 106.Brazil Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 107.Argentina Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 108.Argentina Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 109.Argentina Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 110.Argentina Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 111.Argentina Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 112.Argentina Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 113.Asia-Pacific Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 114.Asia-Pacific Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 115.Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 116.Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 117.Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 118.Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 119.Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 120.India Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 121.India Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 122.India Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 123.India Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 124.India Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 125.India Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 126.China Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 127.China Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 128.China Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 129.China Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 130.China Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 131.China Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 132.Japan Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 133.Japan Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 134.Japan Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 135.Japan Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 136.Japan Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 137.Japan Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 138.Australia Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 139.Australia Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 140.Australia Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 141.Australia Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 142.Australia Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 143.Australia Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 144.Vietnam Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 145.Vietnam Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 146.Vietnam Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 147.Vietnam Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 148.Vietnam Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 149.Vietnam Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 150.South Korea Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 151.South Korea Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 152.South Korea Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 153.South Korea Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 154.South Korea Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 155.South Korea Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 156.Indonesia Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 157.Indonesia Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 158.Indonesia Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 159.Indonesia Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 160.Indonesia Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 161.Indonesia Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 162.Philippines Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 163.Philippines Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 164.Philippines Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 165.Philippines Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 166.Philippines Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 167.Philippines Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 168.Middle East & Africa Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 169.Middle East & Africa Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 170.Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 171.Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 172.Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 173.Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 174.Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 175.Saudi Arabia Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 176.Saudi Arabia Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 177.Saudi Arabia Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 178.Saudi Arabia Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 179.Saudi Arabia Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 180.Saudi Arabia Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 181.UAE Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 182.UAE Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 183.UAE Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 184.UAE Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 185.UAE Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 186.UAE Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 187.South Africa Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 188.South Africa Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 189.South Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 190.South Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 191.South Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 192.South Africa Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 193.By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194.By Animal Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195.By Infection Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023